1.
Eksp Klin Farmakol
; 79(4): 8-11, 2016 Aug.
Artigo
em Inglês, Russo
| MEDLINE
| ID: mdl-29949697
RESUMO
We have studied the physical dependence on and tolerance to the analgesic activity of compound RU-1205. It is established that this compound does not cause side effects typical of morphine and butorphanol including the development of withdrawal syndrome upon naloxone provocation and tolerance to analgesic activity upon 14-day administration.